Medical data says Australia has two million patients of asthma. Moreover, the disease is also severely affecting the children in the country.

If scientist’s claims are to be believed then there is some very good news for all the asthma patients because they are confirming a breakthrough to some new and much effective asthma treatments.

In their latest findings, a team of researchers from the Walter and Eliza Hall Institute in Melbourne, have confirmed their findings of a new asthma treatment by reprogramming immune cells of the patient’s body to lessen the airway damage and inflammation.

Researchers explained that they reprogrammed asthma-promoting cells known as T-Helper 2 (Th2)cells (found from the identification of a key enzyme) by modify their DNA and adding in them certain features to serve with an effective new treatment for chronic inflammatory diseases like asthma.

The above study was led by Walter and Eliza Hall Institute Researcher Dr. Rhys Allan while working at Institut Curie in Paris.

He added that the experiment tried to switch on the genes controlling the Th2 cells that were switched off by the enzyme with the reprogramming method.

“In this study, we discovered that the enzyme plays a critical role in programming these asthma-promoting cells, making it a potential target for new therapies to treat asthma,” he said.